Mitsubishi UFJ Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $217K | Sell |
3,836
-78
| -2% | -$4.55K | ﹤0.01% | 960 |
|
|
2025
Q4 | $233K | Sell |
3,914
-161,663
| -98% | -$8.8M | ﹤0.01% | 995 |
|
|
2025
Q3 | $8.97M | Buy |
165,577
+6
| +0% | +$343 | 0.01% | 601 |
|
|
2025
Q2 | $9.1M | Sell |
165,571
-248
| -0.1% | -$14.6K | 0.01% | 596 |
|
|
2025
Q1 | $11.7M | Buy |
165,819
+22,674
| +16% | +$1.53M | 0.01% | 563 |
|
|
2024
Q4 | $9.57M | Buy |
143,145
+16,471
| +13% | +$1.1M | 0.01% | 589 |
|
|
2024
Q3 | $8.9M | Sell |
126,674
-236
| -0.2% | -$19.7K | 0.01% | 579 |
|
|
2024
Q2 | $10.4M | Buy |
126,910
+20,155
| +19% | +$1.68M | 0.01% | 542 |
|
|
2024
Q1 | $9.32M | Buy |
106,755
+23,156
| +28% | +$2.07M | 0.01% | 544 |
|
|
2023
Q4 | $8.08M | Sell |
83,599
-317
| -0.4% | -$28K | 0.01% | 539 |
|
|
2023
Q3 | $7.42M | Buy |
83,916
+6,768
| +9% | +$602K | 0.02% | 533 |
|
|
2023
Q2 | $6.69M | Buy |
77,148
+10,928
| +17% | +$1.03M | 0.01% | 550 |
|
|
2023
Q1 | $6.44M | Buy |
66,220
+4,512
| +7% | +$468K | 0.02% | 535 |
|
|
2022
Q4 | $6.21M | Buy |
61,708
+3,934
| +7% | +$369K | 0.02% | 533 |
|
|
2022
Q3 | $4.9M | Buy |
57,774
+4,271
| +8% | +$380K | 0.02% | 551 |
|
|
2022
Q2 | $4.43M | Buy |
53,503
+3,832
| +8% | +$305K | 0.02% | 559 |
|
|
2022
Q1 | $3.83M | Sell |
49,671
-594
| -1% | -$49.7K | 0.02% | 616 |
|
|
2021
Q4 | $4.49M | Buy |
50,265
+6,749
| +16% | +$557K | 0.02% | 603 |
|
|
2021
Q3 | $3.36M | Hold |
43,516
| – | – | 0.02% | 642 |
|
|
2021
Q2 | $3.63M | Buy |
43,516
+2,294
| +6% | +$182K | 0.02% | 630 |
|
|
2021
Q1 | $3.11M | Buy |
41,222
+3,817
| +10% | +$312K | 0.02% | 618 |
|
|
2020
Q4 | $3.28M | Buy |
37,405
+499
| +1% | +$39.6K | 0.03% | 543 |
|
|
2020
Q3 | $2.81M | Buy |
36,906
+6,027
| +20% | +$610K | 0.03% | 513 |
|
|
2020
Q2 | $3.81M | Buy |
30,879
+2,302
| +8% | +$229K | 0.04% | 394 |
|
|
2020
Q1 | $2.42M | Sell |
28,577
-1,143
| -4% | -$98.5K | 0.04% | 417 |
|
|
2019
Q4 | $2.5M | Buy |
29,720
+3,603
| +14% | +$272K | 0.03% | 480 |
|
|
2019
Q3 | $1.76M | Sell |
26,117
-2,634
| -9% | -$203K | 0.03% | 488 |
|
|
2019
Q2 | $2.46M | Buy |
28,751
+3,020
| +12% | +$258K | 0.04% | 394 |
|
|
2019
Q1 | $2.29M | Buy |
25,731
+939
| +4% | +$87K | 0.05% | 366 |
|
|
2018
Q4 | $2.09M | Sell |
24,792
-1,945
| -7% | -$185K | 0.05% | 324 |
|
|
2018
Q3 | $2.59M | Buy |
26,737
+2,244
| +9% | +$224K | 0.05% | 342 |
|
|
2018
Q2 | $2.31M | Buy |
24,493
+518
| +2% | +$45.4K | 0.05% | 355 |
|
|
2018
Q1 | $1.94M | Sell |
23,975
-5,356
| -18% | -$460K | 0.05% | 394 |
|
|
2017
Q4 | $2.7M | Sell |
29,331
-1,281
| -4% | -$111K | 0.06% | 322 |
|
|
2017
Q3 | $2.85M | Buy |
30,612
+4,804
| +19% | +$425K | 0.07% | 298 |
|
|
2017
Q2 | $2.34M | Buy |
25,808
+265
| +1% | +$24.1K | 0.06% | 337 |
|
|
2017
Q1 | $2.24M | Buy |
25,543
+399
| +2% | +$35.5K | 0.05% | 374 |
|
|
2016
Q4 | $2.16M | Buy |
25,144
+1,795
| +8% | +$154K | 0.05% | 365 |
|
|
2016
Q3 | $2.16M | Buy |
23,349
+588
| +3% | +$55.4K | 0.05% | 352 |
|
|
2016
Q2 | $1.77M | Buy |
22,761
+692
| +3% | +$58.8K | 0.05% | 392 |
|
|
2016
Q1 | $1.82M | Sell |
22,069
-1,935
| -8% | -$157K | 0.05% | 368 |
|
|
2015
Q4 | $2.52M | Sell |
24,004
-20,563
| -46% | -$2.15M | 0.07% | 267 |
|
|
2015
Q3 | $4.69M | Buy |
44,567
+10,039
| +29% | +$1.34M | 0.15% | 139 |
|
|
2015
Q2 | $4.72M | Buy |
34,528
+1,473
| +4% | +$183K | 0.14% | 144 |
|
|
2015
Q1 | $4.12M | Buy |
33,055
+13,438
| +69% | +$1.42M | 0.12% | 176 |
|
|
2014
Q4 | $1.81M | Sell |
19,617
-2,599
| -12% | -$216K | 0.06% | 362 |
|
|
2014
Q3 | $1.6M | Sell |
22,216
-1,147
| -5% | -$75.4K | 0.05% | 416 |
|
|
2014
Q2 | $1.45M | Sell |
23,363
-1,592
| -6% | -$96.2K | 0.04% | 481 |
|
|
2014
Q1 | $1.7M | Sell |
24,955
-998
| -4% | -$73.5K | 0.05% | 425 |
|
|
2013
Q4 | $1.79M | Sell |
25,953
-2,437
| -9% | -$166K | 0.05% | 392 |
|
|
2013
Q3 | $2.05M | Buy |
28,390
+990
| +4% | +$65.8K | 0.05% | 395 |
|
|
2013
Q2 | $1.53M | Buy |
+27,400
| New | +$1.71M | 0.04% | 465 |
|
Other funds holding BMRN
VCM
VPM
Mitsubishi UFJ Asset Management's BMRN Position: Q1 2026 in Review
Mitsubishi UFJ Asset Management reduced its BioMarin Pharmaceuticals (BMRN) stake by 2% in Q1 2026, selling an estimated $4.55K and leaving 3,836 shares worth $217K. The position accounts for ﹤0.01% of the portfolio, ranked #960.
Mitsubishi UFJ Asset Management first reported a position in BMRN in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.7M in Q1 2025. 554 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.
- Mitsubishi UFJ Asset Management held 3,836 shares of BioMarin Pharmaceuticals worth $217K as of Q1 2026.
- Mitsubishi UFJ Asset Management sold 78 BioMarin Pharmaceuticals shares in Q1 2026, an estimated $4.55K.
- BioMarin Pharmaceuticals made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q1 2026, its #960 holding.
- Mitsubishi UFJ Asset Management first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Mitsubishi UFJ Asset Management's BioMarin Pharmaceuticals position peaked at $11.7M in Q1 2025.
- 554 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.
Based on Mitsubishi UFJ Asset Management's 13F filing for Q1 2026, filed 12 May 2026.